Investing
Cathie Wood's ARK Invest Sells Over 840,000 Shares of Seres Therapeutics
Published:
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.
Here are all the ARK Invest sales on Monday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 981,100 |
ARKF | 9923HK | YEAHKA | 297,200 |
ARKG | PSTI | PLURISTEM THERAPEUTICS | 10,518 |
ARKG | CLLS | CELLECTIS | 7,300 |
ARKG | RHHBY | ROCHE | 78,900 |
ARKK | MCRB | SERES THERAPEUTICS | 846,468 |
ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 71,749 |
ARKQ | ISRG | INTUITIVE SURGICAL | 1,700 |
ARKQ | NXPI | NXP SEMICONDUCTORS | 13,000 |
ARKQ | BABA | ALIBABA | 15,089 |
ARKQ | GOOG | ALPHABET | 4,808 |
ARKW | MELI | MERCADOLIBRE | 4,500 |
ARKW | SE | SEA | 34,049 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.